89bio, Inc.

Historical 13F Holders

Symbol
ETNB
CUSIP
282559103
All holders as of
Q4 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 282559103 since 12/18/2024, largest first.

Filer % of Class Filed
Vanguard Group Inc 13G 5.6% 7/29/2025
Event 6/30/2025
Suvretta Capital Management, LLC 13G/A
5.6% 11/13/2025
Event 9/30/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (7)
Janus Henderson Group PLC 13G/A 3.6% 10/7/2025
Event 9/30/2025
Biotechnology Value Fund L P 13G/A
3.6% 2/14/2025
Event 12/31/2024
RTW Investments, LP 13G/A
1.3% 5/15/2025
Event 3/31/2025
Adage Capital Management, L.P. 13D/A
0% 10/31/2025
Event 10/29/2025
Deep Track Capital, LP 13G/A
0% 2/13/2026
Event 12/31/2025
Pentwater Capital Management LP 13G
0% 11/14/2025
Event 9/30/2025
RA Capital Management, L.P. 13D/A
0% 11/3/2025
Event 10/30/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q4 2 90.0 k $1.11 M
2025 Q3 230 155 M $2.27 B
2025 Q2 208 161 M $1.59 B
2025 Q1 204 154 M $1.14 B
2024 Q4 167 121 M $947 M
2024 Q3 156 105 M $777 M
2024 Q2 157 104 M $830 M
2024 Q1 167 100 M $1.16 B
2023 Q4 168 96.5 M $1.08 B
2023 Q3 189 72.4 M $1.12 B
2023 Q2 170 78.1 M $1.48 B
2023 Q1 183 71.9 M $1.10 B
2022 Q4 119 46.4 M $591 M
2022 Q3 93 40.0 M $232 M
2022 Q2 74 32.5 M $105 M
2022 Q1 72 17.1 M $64.3 M
2021 Q4 54 17.3 M $226 M
2021 Q3 50 17.3 M $339 M
2021 Q2 52 16.9 M $315 M
2021 Q1 71 16.9 M $401 M
2020 Q4 72 16.8 M $409 M
2020 Q3 70 16.0 M $411 M
2020 Q2 40 10.6 M $215 M
2020 Q1 32 10.7 M $270 M
2019 Q4 36 10.5 M $276 M